Vol 9, No 2 (2023)
Review paper
Published online: 2023-06-15

open access

Page views 1372
Article views/downloads 377
Get Citation

Connect on Social Media

Connect on Social Media

Everything you always wanted to know about systemic sclerosis but were afraid to ask: Part 1. Clinical pictures

Magdalena Kopeć-Mędrek12, Monika Bultrowicz2, Olga Gumkowska-Sroka3, Barbara Buc-Piorun2, Klaudia Palka2, Karolina Nowak2, Przemysław Kotyla132
Rheumatology Forum 2023;9(2):63-72.


The authors present the clinical picture of systemic sclerosis including organ and system involvement.

Article available in PDF format

View PDF Download PDF file


  1. Didier K, Robbins A, Antonicelli F, et al. Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities [article in French]. Rev Med Interne. 2019; 40(10): 654–663.
  2. Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011; 70(3): 476–481.
  3. Wollheim FA. Classification of systemic sclerosis: vision and reality. Rheumatology (Oxford). 2005; 44(10): 1212–1216.
  4. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013; 65(11): 2737–2747.
  5. Sierakowski S, Sierakowska M. Twardzina układowa. In: Zimmermann-Górska I. ed. Reumatologia kliniczna. PZWL Wydawnictwo Lekarskie, Warszawa 2008: 603–605.
  6. Cutolo M. Atlas of capillaroscopy in rheumatic diseases. Elsevier 2010.
  7. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017; 390(10103): 1685–1699.
  8. Racine M, Hudson M, Baron M, et al. The impact of pain and itch on functioning and health-related quality of life in systemic sclerosis: an exploratory study. J Pain Symptom Manage. 2016; 52(1): 43–53.
  9. Medsger TA, Benedek TG. History of skin thickness assessment and the Rodnan skin thickness scoring method in systemic sclerosis. J Scleroderma Relat Disord. 2019; 4(2): 83–88.
  10. Jerjen R, Nikpour M, Krieg T, et al. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. J Am Acad Dermatol. 2022; 87(5): 937–954.
  11. Valido A, Cordeiro I. Calcinosis in systemic sclerosis. N Engl J Med. 2019; 381(17): 1663.
  12. Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G i wsp. EUSTAR.
  13. Siegert E, Uruha A, Goebel HH, et al. Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology. Acta Neuropathol. 2021; 141(6): 917–927.
  14. Leurs A, Dubucquoi S, Machuron F, et al. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study. Joint Bone Spine. 2021; 88(1): 105048.
  15. Cappelli S, Bellando Randone S, Camiciottoli G, et al. Interstitial lung disease in systemic sclerosis: where do we stand? Eur Respir Rev. 2015; 24(137): 411–419.
  16. Distler O, Assassi S, Cottin V, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020; 55(5): 1902026.
  17. Orlandi M, Meliante LA, Damiani A, et al. The role of bronchoalveolar lavage in systemic sclerosis interstitial lung disease: A systematic literature review. Pharmaceuticals (Basel). 2022; 15(12): 1584.
  18. Pugnet G, Marjanovic Z, Deligny C, et al. Reproducibility and utility of the 6-minute walk test in systemic sclerosis. J Rheumatol. 2018; 45(9): 1273–1280.
  19. Bruni C, Ross L. Cardiac involvement in systemic sclerosis: Getting to the heart of the matter. Best Pract Res Clin Rheumatol. 2021; 35(3): 101668.
  20. Alexander EL, Firestein GS, Weiss JL, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med. 1986; 105(5): 661–668.
  21. Allanore Y, Meune C, Kahan A. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies. Curr Opin Rheumatol. 2008; 20(6): 697–702.
  22. Ahmed Z, Saxena P. Effusive constrictive pericarditis in systemic sclerosis. Eur J Rheumatol. 2021; 8(1): 53–54.
  23. Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis. 2009; 68(12): 1878–1884.
  24. Allanore Y, Komocsi A, Vettori S, et al. N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis. Int J Cardiol. 2016; 223: 385–389.
  25. Lechartier B, Humbert M. Pulmonary arterial hypertension in systemic sclerosis. Presse Med. 2021; 50(1): 104062.
  26. Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019; 53(1): 1801887.
  27. D'Alto M, Romeo E, Argiento P, et al. Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. Int J Cardiol. 2013; 168(4): 4058–4062.
  28. Frech TM, Mar D. Gastrointestinal and hepatic disease in systemic sclerosis. Rheum Dis Clin North Am. 2018; 44(1): 15–28.
  29. Hughes M, Ong VH, Anderson ME, et al. Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Rheumatology (Oxford). 2015; 54(11): 2015–2024.
  30. Ingraham KM, O'Brien MS, Shenin M, et al. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol. 2010; 37(3): 603–607.
  31. Marie I, Ducrotté P, Denis P, et al. Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up. Rheumatology (Oxford). 2007; 46(1): 150–153.
  32. Assassi S, Fritzler MJ, Arnett FC, et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol. 2009; 36(10): 2250–2256.
  33. Chrabaszcz M, Małyszko J, Sikora M, et al. Renal involvement in systemic sclerosis: an update. Kidney Blood Press Res. 2020; 45(4): 532–548.
  34. Wielosz E. Zajęcie nerek w twardzinie układowej. Przegląd Reumatologiczny. 2008; 1(19): 3–4.
  35. Bütikofer L, Varisco PA, Distler O, et al. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. Arthritis Res Ther. 2020; 22(1): 59.